135 related articles for article (PubMed ID: 23725141)
1. Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors.
Zheng SR; Guo GL; Zhai Q; Zou ZY; Zhang W
Asian Pac J Cancer Prev; 2013; 14(4):2361-6. PubMed ID: 23725141
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
Xu D; Ma P; Gao G; Gui Y; Niu X; Jin B
Tumour Biol; 2015 Sep; 36(10):7743-53. PubMed ID: 25936342
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of knocking down microRNA-221 and microRNA-222 on glioma cell growth in vitro and in vivo].
Zhang CZ; Kang CS; Pu PY; Wang GX; Jia ZF; Zhang AL; Han L; Xu P
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):721-6. PubMed ID: 20021821
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT
Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318
[TBL] [Abstract][Full Text] [Related]
5. [Effect of antisense miR-224 on gastric cancer cell proliferation and apoptosis].
Mao S; He N; Xin L; Zeng F; Cao J
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):92-6. PubMed ID: 24796455
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
[TBL] [Abstract][Full Text] [Related]
7. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.
Hu F; Meng X; Tong Q; Liang L; Xiang R; Zhu T; Yang S
Biochim Biophys Acta; 2013 Dec; 1832(12):2379-90. PubMed ID: 24012720
[TBL] [Abstract][Full Text] [Related]
8. Experimental study on inhibition effects of the XAF1 gene against lung cancer cell proliferation.
Yang WT; Chen DL; Zhang FQ; Xia YC; Zhu RY; Zhou DS; Chen YB
Asian Pac J Cancer Prev; 2014; 15(18):7825-9. PubMed ID: 25292071
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
Li J; Huang H; Sun L; Yang M; Pan C; Chen W; Wu D; Lin Z; Zeng C; Yao Y; Zhang P; Song E
Clin Cancer Res; 2009 Jun; 15(12):3998-4008. PubMed ID: 19509158
[TBL] [Abstract][Full Text] [Related]
10. Regulating A549 cells growth by ASO inhibiting miRNA expression.
Wang PY; Li YJ; Zhang S; Li ZL; Yue Z; Xie N; Xie SY
Mol Cell Biochem; 2010 Jun; 339(1-2):163-71. PubMed ID: 20049626
[TBL] [Abstract][Full Text] [Related]
11. [Study on effects of microRNA-21 antisense oligonucleotide in vivo and in vitro on bionomics of human cervical squamous carcinoma cell lines SiHa].
Wang XM; Xu J; Cheng ZQ; Peng QZ; Hu JT; Gao LK; Zhang SF; Jin HT
Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):254-9. PubMed ID: 22800522
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis.
Zheng SR; Guo GL; Zhang W; Huang GL; Hu XQ; Zhu J; Huang QD; You J; Zhang XH
Oncol Rep; 2012 Apr; 27(4):1149-55. PubMed ID: 22245916
[TBL] [Abstract][Full Text] [Related]
13. ER81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro.
Chen Y; Zou H; Yang LY; Li Y; Wang L; Hao Y; Yang JL
Asian Pac J Cancer Prev; 2012; 13(5):2385-92. PubMed ID: 22901226
[TBL] [Abstract][Full Text] [Related]
14. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
[TBL] [Abstract][Full Text] [Related]
15. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
[TBL] [Abstract][Full Text] [Related]
16. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
17. miR-21-mediated tumor growth.
Si ML; Zhu S; Wu H; Lu Z; Wu F; Mo YY
Oncogene; 2007 Apr; 26(19):2799-803. PubMed ID: 17072344
[TBL] [Abstract][Full Text] [Related]
18. Proteasomes reactivator REG gamma enchances oncogenicity of MDA-MB-231 cell line via promoting cell proliferation and inhibiting apoptosis.
Tian M; Xiaoyi W; Xiaotao L; Guosheng R
Cell Mol Biol (Noisy-le-grand); 2009 Jun; 55 Suppl():OL1121-31. PubMed ID: 19656465
[TBL] [Abstract][Full Text] [Related]
19. A soluble truncated cadherin induces breast cancer cell apoptosis and growth inhibition.
Shi XY; Lu H; Li WL; Tang HL; Xiong JJ; Zhang JQ; Opolon P; Legrand C; Perricaudet M; Li H
J Cancer Res Clin Oncol; 2006 Sep; 132(9):561-71. PubMed ID: 16763806
[TBL] [Abstract][Full Text] [Related]
20. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
